266 related articles for article (PubMed ID: 31419967)
1. Association of plasma macrophage colony-stimulating factor with cardiovascular morbidity and all-cause mortality in chronic hemodialysis patients.
Deng X; Yang Q; Wang Y; Yang Y; Pei G; Zhu H; Wu J; Wang M; Zhao Z; Xu H; Zhou C; Guo Y; Yao Y; Zhang Z; Liao W; Zeng R
BMC Nephrol; 2019 Aug; 20(1):321. PubMed ID: 31419967
[TBL] [Abstract][Full Text] [Related]
2. Marked increases in macrophage colony-stimulating factor and interleukin-18 in maintenance hemodialysis patients: comparative study of advanced glycation end products, carboxymethyllysine and pentosidine.
Uchimura T; Motomiya Y; Okamura H; Hashiguchi T; Miura M; Uji Y; Iwamoto H; Maruyama I
Nephron; 2002 Apr; 90(4):401-7. PubMed ID: 11961398
[TBL] [Abstract][Full Text] [Related]
3. Levels of serum colony-stimulating factors (CSFs) in patients on long-term haemodialysis.
Sato H; Ohkubo M; Nagaoka T
Cytokine; 1994 Mar; 6(2):187-94. PubMed ID: 7518261
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of macrophage-colony stimulating factor in the pathogenesis of cardiac dysfunction in hemodialysis patients.
Ito A; Shimokawa H; Meno H; Inou T
Jpn Heart J; 2004 May; 45(3):497-503. PubMed ID: 15240969
[TBL] [Abstract][Full Text] [Related]
5. Oxidized high-density lipoprotein as a risk factor for cardiovascular events in prevalent hemodialysis patients.
Honda H; Ueda M; Kojima S; Mashiba S; Michihata T; Takahashi K; Shishido K; Akizawa T
Atherosclerosis; 2012 Feb; 220(2):493-501. PubMed ID: 22119537
[TBL] [Abstract][Full Text] [Related]
6. Impact of metabolic disturbances and malnutrition-inflammation on 6-year mortality in Japanese patients undergoing hemodialysis.
Nakagawa N; Matsuki M; Yao N; Hirayama T; Ishida H; Kikuchi K; Hasebe N
Ther Apher Dial; 2015 Feb; 19(1):30-9. PubMed ID: 25196142
[TBL] [Abstract][Full Text] [Related]
7. Impact of arteriovenous fistula blood flow on serum il-6, cardiovascular events and death: An ambispective cohort analysis of 64 Chinese hemodialysis patients.
Hu Z; Zhu F; Zhang N; Zhang C; Pei G; Wang P; Yang J; Guo Y; Wang M; Wang Y; Yang Q; Zhu H; Liao W; Zhang Z; Yao Y; Zeng R; Xu G
PLoS One; 2017; 12(3):e0172490. PubMed ID: 28267753
[TBL] [Abstract][Full Text] [Related]
8. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients.
Qureshi AR; Alvestrand A; Divino-Filho JC; Gutierrez A; Heimbürger O; Lindholm B; Bergström J
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S28-36. PubMed ID: 11792759
[TBL] [Abstract][Full Text] [Related]
9. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
Refaat H; Sany D; Mohab A; Ezzat H
Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
[TBL] [Abstract][Full Text] [Related]
10. Inflammation predicts all-cause and cardiovascular mortality in haemodialysis patients.
Selim G; Stojceva-Taneva O; Zafirovska K; Sikole A; Gelev S; Dzekova P; Stefanovski K; Koloska V; Polenakovic M
Prilozi; 2006 Jul; 27(1):133-44. PubMed ID: 16985487
[TBL] [Abstract][Full Text] [Related]
11. Increased Inflammatory Response in Association with the Initiation of Hemodialysis Compared with Peritoneal Dialysis in a Prospective Study of End-Stage Kidney Disease Patients.
Yong K; Dogra G; Boudville N; Lim W
Perit Dial Int; 2018; 38(1):18-23. PubMed ID: 29097485
[TBL] [Abstract][Full Text] [Related]
12. Cardiothoracic Ratio and All-Cause Mortality and Cardiovascular Disease Events in Hemodialysis Patients: The Q-Cohort Study.
Yotsueda R; Taniguchi M; Tanaka S; Eriguchi M; Fujisaki K; Torisu K; Masutani K; Hirakata H; Kitazono T; Tsuruya K
Am J Kidney Dis; 2017 Jul; 70(1):84-92. PubMed ID: 28196648
[TBL] [Abstract][Full Text] [Related]
13. Low cholesterol along with inflammation predicts morbidity and mortality in hemodialysis patients.
Tsirpanlis G; Boufidou F; Zoga M; Triantafyllis G; Fatourou A; Stamatelou K; Bleta A; Petrihou C; Chatzipanagiotou S; Nicolaou C
Hemodial Int; 2009 Apr; 13(2):197-204. PubMed ID: 19432694
[TBL] [Abstract][Full Text] [Related]
14. Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.
Carrero JJ; Ortiz A; Qureshi AR; Martín-Ventura JL; Bárány P; Heimbürger O; Marrón B; Metry G; Snaedal S; Lindholm B; Egido J; Stenvinkel P; Blanco-Colio LM
Clin J Am Soc Nephrol; 2009 Jan; 4(1):110-8. PubMed ID: 18945991
[TBL] [Abstract][Full Text] [Related]
15. Carotid plaques and their predictive value for cardiovascular disease and all-cause mortality in hemodialysis patients considering renal transplantation: a decade follow-up.
Schwaiger JP; Lamina C; Neyer U; König P; Kathrein H; Sturm W; Lhotta K; Gröchenig E; Dieplinger H; Kronenberg F
Am J Kidney Dis; 2006 May; 47(5):888-97. PubMed ID: 16632029
[TBL] [Abstract][Full Text] [Related]
16. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
[TBL] [Abstract][Full Text] [Related]
17. Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients.
Ohya M; Otani H; Kimura K; Saika Y; Fujii R; Yukawa S; Shigematsu T
Clin Exp Nephrol; 2011 Dec; 15(6):877-83. PubMed ID: 21850576
[TBL] [Abstract][Full Text] [Related]
18. [Mediators of amyloidogenesis and cytokines in dialysis-related amyloidosis].
Rysavá R; Merta M; Tesar V; Lachmanová J; Sulková S; Bláha J
Cas Lek Cesk; 2002 Apr; 141(8):244-7. PubMed ID: 12038073
[TBL] [Abstract][Full Text] [Related]
19. Carotid atherosclerosis and endothelial cell adhesion molecules as predictors of long-term outcome in chronic hemodialysis patients.
Papagianni A; Dovas S; Bantis C; Belechri AM; Kalovoulos M; Dimitriadis C; Efstratiadis G; Alexopoulos E; Memmos D
Am J Nephrol; 2008; 28(2):265-74. PubMed ID: 17989499
[TBL] [Abstract][Full Text] [Related]
20. Human serum paraoxonase concentration predicts cardiovascular mortality in hemodialysis patients.
Ikeda Y; Suehiro T; Itahara T; Inui Y; Chikazawa H; Inoue M; Arii K; Hashimoto K
Clin Nephrol; 2007 Jun; 67(6):358-65. PubMed ID: 17598371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
